1. Home
  2. ATHM vs IDYA Comparison

ATHM vs IDYA Comparison

Compare ATHM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

HOLD

Current Price

$20.80

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.48

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATHM
IDYA
Founded
2008
2015
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ATHM
IDYA
Price
$20.80
$33.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
14
Target Price
$28.00
$49.67
AVG Volume (30 Days)
418.6K
923.6K
Earning Date
02-19-2026
02-13-2026
Dividend Yield
8.55%
N/A
EPS Growth
N/A
N/A
EPS
1.73
N/A
Revenue
$951,436,680.00
$214,834,000.00
Revenue This Year
N/A
$2,688.43
Revenue Next Year
$2.29
N/A
P/E Ratio
$12.11
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$20.68
$13.45
52 Week High
$32.70
$39.28

Technical Indicators

Market Signals
Indicator
ATHM
IDYA
Relative Strength Index (RSI) 31.20 44.29
Support Level $22.72 $31.62
Resistance Level $23.12 $34.66
Average True Range (ATR) 0.60 1.41
MACD -0.18 -0.28
Stochastic Oscillator 8.53 32.56

Price Performance

Historical Comparison
ATHM
IDYA

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: